Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-11 · accession 0001127602-24-018365 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,422 | 142.8K | +4% | +$43.2K |
| DM | 2024-06-11 | 2024-06-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $53.04 | -7,788 | 135.0K | -5% | -$413.1K |
| D | 2024-06-11 | 2024-06-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $0.00 | -5,422 | 68.9K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | M | A | 5,422 | $7.96 | 142,792 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-11 | S | D | 5,422 | $53.05 | 137,370 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-11 | S | D | 2,366 | $53.03 | 135,004 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-06-11 | M | D | 5,422 | $0.00 | 68,900 | D | $7.96 · 2015-03-26 to 2025-02-26 | 5,422 Common Stock |